FDA registered. Hydromer is ISO 9001:2015 certified with TUV Rheinland of North America. ISO 13485:2016 is certified with BSI.

FDA registered. Hydromer is ISO 9001:2015 certified with TUV Rheinland of North America. ISO 13485:2016 is certified with BSI.

Investor Relations

Hydromer® has been a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 40 years. As a trusted partner to large and small companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. We are an FDA, GMP/ISO 13485, and ISO 9001 production facility located in Concord, North Carolina.

Want to learn more about Hydromer? Get in touch today!

Recent News

Interested to learn more about Hydromer? Get in touch with us today.

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update
Hydromer Announces Attainment of ISO 13485 Certification
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024
Hydromer, Inc Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations
Hydromer, Inc. Unveils Rebranding Initiatives Reflecting Its Transformation and Focus on Growth and Innovation
Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors
Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti
Hydromer, Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara
Hydromer, Inc. Announces Removal of CEO
Hydromer, Inc. Appoints New CEO

Investor FAQs

Fill out or form below the FAQ’s to be added to our emailing list!

Our fiscal year ends on 12/31.

Contact our finance team for more information or mail all investor inquiries to:

Send us a Message

Create an account to access this functionality.
Discover the advantages